The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-25), DocMorris AG's 5-Day RSI is 45.83.
The industry rank for DocMorris AG's 5-Day RSI or its related term are showing as below:
XSWX:DOCM's 5-Day RSI is ranked better than 51.79% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 46.81
vs XSWX:DOCM: 45.83
DocMorris AG (XSWX:DOCM) 5-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
DocMorris AG 5-Day RSI Related Terms
DocMorris AG 5-Day RSI Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG 5-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where DocMorris AG's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a 5-Day RSI of 45.83 as of Jun. 25, 2026. According to the industry distribution chart, DocMorris AG ranks #336 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 48.2%.
Is DocMorris AG's 5-Day RSI too high?
DocMorris AG's current 5-Day RSI is 45.83. The Healthcare Providers & Services industry median 5-Day RSI is 46.81. DocMorris AG's value of 45.83 is 2.1% below this industry median. Based on the distribution chart, DocMorris AG ranks #336 out of 697 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's 5-Day RSI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #336 out of 697 companies for 5-Day RSI. This puts DocMorris AG in the upper half of its industry. The industry median 5-Day RSI is 46.81. DocMorris AG's value of 45.83 is 2.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Healthcare Providers & Services company?
The median 5-Day RSI among Healthcare Providers & Services companies is 46.81, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current 5-Day RSI of 45.83 is 2.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 5-Day RSI is 46.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current 5-Day RSI is 45.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF7.92 — trading 24.8% below its estimated fair value. The current 5-Day RSI is 45.83 and 2.1% below the Healthcare Providers & Services industry median of 46.81. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current 5-Day RSI is 45.83 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF7.92 is trading 24.8% below its estimated GF Value™ of CHF10.53.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
5-Day RSI: 45.83
GF Value™: CHF10.53 vs. price of CHF7.92 (24.8% below fair value)
Industry Position: 2.1% below the Healthcare Providers & Services median (#336 of 697)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 